ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day

2 years ago

Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep…

Inovalon Launches Registration Assurance Solution for Healthcare Providers

2 years ago

Newest Provider Offering Improves Patient Experience, Registration Speed, and Coverage Accuracy, Reducing Coverage-Related Revenue LossesBOWIE, Md., March 14, 2022 (GLOBE…

Novan, Inc. to Present at Two Upcoming Investor Conferences

2 years ago

DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula…

GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally

2 years ago

GreenLight test tubes Serum Institute of India (SII) is the world’s largest vaccine manufacturer by number of doses produced and…

Genmab Announces the Nomination of a New Member of the Company’s Board of Directors

2 years ago

Company Announcement Genmab’s Board of Directors proposes that Elizabeth O’Farrell is elected as a new member of the Board of…

Little Leaves Behavioral Services’ Senior Vice President of Operations Amie Perl Honored as Provider Advocate of the Year at the 15th Annual Autism Law Summit

2 years ago

SILVER SPRING, Md., March 14, 2022 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health…

ICU Medical, Inc. to Participate at the KeyBanc Life Sciences & MedTech Investor Forum

2 years ago

SAN CLEMENTE, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…

Biomea Fusion Announces Presentation of Lead Menin Inhibitor BMF-219 in Diabetes at ADA 82nd Scientific Sessions 2022

2 years ago

Biomea to present preclinical data from multiple in vivo studiesBiomea plans to initiate a Phase I/II clinical trial of BMF-219…

Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19

2 years ago

DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continueSAN DIEGO, March 14, 2022…

Breast CT Authority and Head of Clinical Trials Joins Izotropic

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the…